β-sitosterol is known to have a wide range of antitumor effects, and Wang et al. (Wang Z. et al., 2020) found that β-sitosterol can mediate the p53/NF-κB/BCRP signaling axis to modulate the response of CRC to chemotherapy. Here, NFKB1 is linked to colorectal carcinoma.